Diligence memo · auto-generated · as of July 2, 2026
Ascendance Biotechnology, Inc.
Ascendance Biotechnology, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Ascendance Biotechnology, Inc. operates in Biotechnology, based in MEDFORD.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Ascendance Biotechnology, Inc. has raised $880K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $650K on 2015-12-09.
Most recent recorded round closed around 2016-05-05.
Valuation (modeled)modeled
Provath models Ascendance Biotechnology, Inc. at approximately $13M (range $123K–$144M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.60× the median modeled value of Pre-Seed Biotechnology companies in 2016–2018 (152 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 5 months.
Last raise 10.2 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 2.8× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 16% of Biotechnology peers (4293 compared).
Modeled value ranks above 21% of those peers.
Closest niche peers: New Vital Signs, Inc., Cerebral Magnetics INC, NutriBand Inc., Jivana Biotechnology Inc, AnTolRx, Inc..
Peoplefiled
9 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.